CARDIOMETABOLIC HEALTH CONGRESSDiabetes Management Digital Education Hub

DIABETES MANAGEMENT

CME/CE Activities

Clinical Brief

Why Should We Use CGM in Patients With Type 2 Diabetes?

Virtual Symposium

Assessing the Evolving Role of GLP1-RAs to Reduce Cardiovascular Risk

Virtual Symposium

CGM - Going Beyond HbA1c in T2D Management

Expert Highlights and Perspectives

Vanita R. Aroda, MD
Vanita R. Aroda,
MD
Marie E. McDonnell,
MD
Jorge Plutzky,
MD
ASSESSING THE EVOLVING ROLE OF GLP1-RAS TO REDUCE CV RISK(Recorded January 2023)
Leigh Perreault, MD
Leigh Perreault,
MD
PREDIABETES: SCREENING, DIAGNOSIS, AND MANAGEMENT(Recorded April 2022)
Athena Philis-Tsimikas,
MD
DUAL GLP-1/GIP AGONISTS: ARE THEY THE NEXT BIG THING IN DIABETES TREATMENT(Recorded April 2022)
Lawrence A. Leiter,
MD
HOW CAN WE CONVERGE THE GLUCOCENTRIC AND CARDIO-RENAL RISK MANAGEMENT IN DIABETES PATIENTS(Recorded April 2022)
Grazia Aleppo,
MD
THE EVOLUTION OF INSULIN: A 2022 UPDATE(Recorded April 2022)
Steven J. Russell
MD, PhD
TECHNOLOGY IN DIABETES BEYOND CGM(Recorded April 2022)
Anne L. Peters,
MD
Steven J. Russell
MD, PhD
PANEL DISCUSSION ON DIABETES TECHNOLOGY: CGM AND BEYOND(Recorded April 2022)
Anne L. Peters,
MD
Leigh Perreault, MD
Leigh Perreault,
MD
Lawrence A. Leiter,
MD
Grazia Aleppo,
MD
PERSPECTIVES ON DIABETES MANAGEMENT(Recorded April 2022)

Additional Resources

American Diabetes Association – 2022 Standards of Medical Care in Diabetes
Diabetes Technology – Standards of Medical Care in Diabetes – 2022
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes – 2022
AACE: 2021 Advances Diabetes Technology Guideline
AHA Scientific Statement: Comprehensive Management of Cardiovascular Risk Factors For Adults with Type 2 Diabetes
CGM Metrics and Interpretation
Features of Available CGM Systems
Personal & Professional CGM Billing
Interfering Substances in CGM Systems

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.